Mesirow Financial Investment Management, Inc.

Position in LLY — ELI LILLY & Co

CIK 1469475 CHICAGO, IL

Back to LLY Full portfolio

Position in LLY

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$18,097,001

+$4,493,603 QoQ

Shares Held

15,088

+2.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#932

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Mesirow Financial Investment Management, Inc. holds $112,278,631 across 12 Drug Manufacturers - General names. LLY ranks #3 (16.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	158,995	$40,009,501
2	JNJ	Johnson & Johnson	115,650	$29,371,630
3	LLY	ELI LILLY & Co This page	15,088	$18,097,001
4	PFE	Pfizer Inc	399,667	$9,623,981
5	AMGN	Amgen Inc	14,518	$5,257,258
6	MRK	Merck & Co., Inc.	39,351	$5,056,603
7	BMY	Bristol Myers Squibb Co	32,023	$1,845,165
8	GSK	GSK plc	17,087	$895,700

All Filings in LLY

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,097,001	15,088	+2.0%	Shares	Sole	2026-07-22
2026-03-31	$13,603,398	14,790	+5.6%	Shares	Sole	2026-04-21
2025-12-31	$15,054,118	14,008	-9.6%	Shares	Sole	2026-02-05
2025-09-30	$11,822,685	15,495	+1.4%	Shares	Sole	2025-11-12
2025-06-30	$11,907,320	15,275	-2.5%	Shares	Sole	2025-08-04
2025-03-31	$12,942,835	15,671	-2.3%	Shares	Sole	2025-05-08
2024-12-31	$12,387,512	16,046	+0.3%	Shares	Sole	2025-02-07
2024-09-30	$14,177,697	16,003	+0.7%	Shares	Sole	2024-11-01
2024-06-30	$14,388,298	15,892	-1.4%	Shares	Sole	2024-08-09
2024-03-31	$12,540,715	16,120	+10.6%	Shares	Sole	2024-04-25
2023-12-31	$8,494,310	14,572	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.